NSC |
Compound |
Enrichment |
Correlation |
NSC 750285 |
DP1 |
0.0119221520283057 |
0.42664196 |
NSC 85700 |
Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) |
0.0119221520283057 |
0.37631064 |
NSC 132275 |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.0122129861493296 |
0.38453111 |
NSC 134459 |
Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) |
0.0122129861493296 |
0.61251082 |
NSC 134723 |
K 31 |
0.0122129861493296 |
0.585217 |
NSC 176323 |
Camptothecin Derivative |
0.0122129861493296 |
0.4848964 |
NSC 261726 |
ICN 4221 |
0.0122129861493296 |
0.29727923 |
NSC 372939 |
Null |
0.0122129861493296 |
0.52771776 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.0122129861493296 |
0.55848121 |
NSC 642009 |
Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester |
0.0122129861493296 |
0.20371278 |